DARWIN EU Advisory Board meeting: 14 November 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 14 November 2025, 09:00 (CET) to 14 November 2025, 13:00 (CET)

DARWIN EU Advisory Board meeting: 14 November 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 14 November 2025, 09:00 (CET) to 14 November 2025, 13:00 (CET)

Human medicines European public assessment report (EPAR): Prevenar 20 (previously Apexxnar), pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Date of authorisation: 14/02/2022, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Prevenar 20 (previously Apexxnar), pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Date of authorisation: 14/02/2022, Revision: 14, Status: Authorised

Opinion/decision on a Paediatric investigation plan (PIP): Verzenios, abemaciclib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Nervous system disorders, PIP number: EMA/PE/0000258705

Opinion/decision on a Paediatric investigation plan (PIP): Verzenios, abemaciclib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Nervous system disorders, PIP number: EMA/PE/0000258705

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness